HMN 2025: How IVF and IUI being pregnant charges stay steady throughout Europe, regardless of an growing uptake of single embryo switch

Fewer in vitro fertilization (IVF) and intrauterine insemination (IUI) cycles have been reported in Europe in 20202, however medical being pregnant charges remained steady, based on information offered on the forty first Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE).

The work can also be published within the journal Human Reproduction.

Preliminary information from the ESHRE European IVF Monitoring (EIM) Consortium reveals a gradual and progressive rise in the usage of assisted reproductive know-how (ART). In 2022, a complete of 960,347 ART therapy cycles have been reported by 1,371 clinics throughout 39 European international locations, a 15.6% discount from the 1,137,177 cycles reported in 2021.

Of these 2022 therapy cycles, 137,148 have been IVF, 317,415 intracytoplasmic sperm injection (ICSI), 365,905 frozen embryo transfers (FET), 92,677 preimplantation genetic testing (PGT), and 41,138 oocyte donation (OD) cycles.

In addition, information reported 126,185 IUI therapies utilizing associate semen and 42,532 utilizing donor semen. A complete of 30,758 fertility preservation interventions, together with oocyte, ovarian tissue, semen, and testicular tissue banking, have been reported from 14 international locations.

Clinical being pregnant charges remained broadly steady between 2021 and 2022. For IVF, the speed per aspiration/thawing was 26.3% in 2021 and 25.8% in 2022, whereas the speed per switch was 33.5% and 32.7%, respectively.

For ICSI, being pregnant charges per aspiration have been 23.9% in 2021 versus 24.0% in 2022, and per switch have been 33.5% versus 32.5%. Pregnancy charges utilizing FET have been 37.0% in 2021, in comparison with 36.6% in 2022.

The use of single embryo switch continued to extend, rising from 60.5% in 2021 to 62.6% in 2022. Correspondingly, singleton supply charges improved from 90.4% to 91.5%, whereas twin deliveries declined from 9.5% to eight.4%. Triplet deliveries remained steady at 0.1%.

Chair of the EIM Consortium, Professor Dr. Diane De Neubourg said, “The report confirms the continued excessive utilization of ART and IUI throughout Europe, with over 960,000 therapy cycles reported in 2022 alone. While whole reported cycles decreased barely in comparison with 2021, medical being pregnant charges remained steady, and singleton beginning charges continued to rise, reflecting rising adoption of single embryo switch.

“As the most important dataset on medically assisted copy in Europe, the EIM report stays a significant software for enhancing transparency, high quality assurance, and long-term vigilance in reproductive drugs.”

Professor Dr. Karen Sermon, Chair of ESHRE, added, “This yr’s report highlights the significance of constant, collaborative information assortment throughout Europe. Despite a slight decline in total therapy cycles in 2022, the steady being pregnant charges and continued uptake of single embryo switch replicate regular progress in medical practice.

“By strengthening standardized reporting, we proceed to drive enhancements in care high quality and outcomes for sufferers present process medically assisted copy.”

Data assortment and reporting:

The ESHRE EIM report represents the most important information assortment on medically assisted copy in Europe. Since 1997, ART information aggregated by nationwide registries, clinics, or skilled societies have been collected and analyzed by the EIM. This yr’s information, protecting therapies from January 1 to December 31, 2022, have been offered by nationwide registries or medical associations from 39 European international locations.

The authors be aware of their presentation that the findings must be interpreted with warning, because the strategies of information assortment and ranges of completeness of reported information range amongst European international locations.